RecruitingNot ApplicableNCT06068270

Effect of MOPs During Orthodontic Movement in Periodontitis Patients

Randomized Clinical Trial on the Effect of Micro-osteoperforations (MOPs) During Intrusion of Flared Upper Anterior Teeth in Stage IV Periodontitis Patients


Sponsor

Universidad Complutense de Madrid

Enrollment

28 participants

Start Date

Dec 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Micro-osteoperforations (MOPs) cause cortical bone injuries and consequently increase the expression of inflammatory mediators, allowing for increased bone and periodontal ligament remodeling associated with orthodontic movement. It remains unclear the effect of orthodontic intrusion combined with MOPs application on teeth with reduced periodontium. The general objective will be to determine the efficacy of MOPs during orthodontic tooth movement (OTM) in terms of periodontal and orthodontic outcomes in stage IV periodontitis patients, case type 2 with pathological tooth migration (PTM), characterized the presence of at least one flared tooth of the upper-anterior sextant with an intrabony defect (intrabony component \<5mm)


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

  • Patients will be included if agreeing to undertake combined periodontal and orthodontic therapy following the clinical practice guideline of stage IV periodontitis patients, and fulfilling the following criteria:
  • adult patients older than 18-year-old;

Exclusion Criteria10

  • diagnosed as stage IV (Papapanou et al., 2018) case-type 2 (Herrera et al. 2022) periodontitis;
  • the presence of at least one flared tooth of the upper-anterior sextant with an intrabony defect (intrabonny component <5mm) (experimental teeth);
  • in need of orthodontic therapy.
  • systemic diseases (diabetes mellitus, obesity, cardiovascular diseases);
  • any medication that could affect the level of inflammation, (such as chronic antibiotics, phenytoin, cyclosporin, anti-inflammatory drugs, systemic corticosteroids, or calcium channel blockers);
  • pregnant or lactating woman;
  • inability to respond questions or to attend follow-up visits;
  • extreme skeletal malocclusions requiring orthognathic surgery;
  • patients smoking more than 10 cigarettes/day; and
  • the presence of PD greater or equal to 5mm with BOP after step 3 of periodontal therapy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMicro-ostoperforations (MOPs)

3 MOPs will be performed in the bone next to the root of the experimental tooth. MOPs will be performed using the Excellerator® (Propel Orthodontics, Denstply, Sirona)


Locations(1)

Faculty of Odontology, University Complutense Madrid

Madrid, Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06068270


Related Trials